|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 96, 849-851, Copyright © 1989 by American College of Chest Physicians
ARTICLES |
RC Bone, R Maunder, G Slotman, H Silverman, TM Hyers, MD Kerstein and JJ Ursprung
Rush-Presbyterian St. Lukes Medical Center, Chicago.
Patients with established adult respiratory distress syndrome (ARDS) have a mortality rate that exceeds 50 percent. We analyzed the magnitude of hypoxemia as manifest by the PaO2/FIO2 ratio and its early response to conventional therapy including positive end-expiratory pressure (PEEP) in the placebo group of a large multicenter study. The PaO2/FIO2 ratio was not different at the time of diagnosis of ARDS in those patients who lived compared to those who subsequently died. After one day of conventional therapy including PEEP, those patients who survived increased their PaO2/FIO2 ratio. The nonsurvivors did not improve over a seven-day course. The difference in the PaO2/FIO2 ratio was significant throughout the seven-day observation period. We conclude that the early response to conventional therapy picks a patient population with a good prognosis and can be used as a test of likely survival from ARDS.
This article has been cited by other articles:
![]() |
M. F. El-Khatib and G. W. Jamaleddine A New Oxygenation Index for Reflecting Intrapulmonary Shunting in Patients Undergoing Open-Heart Surgery Chest, February 1, 2004; 125(2): 592 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. K. Lew, T.-K. Kwek, D. Tai, A. Earnest, S. Loo, K. Singh, K. M. Kwan, Y. Chan, C. F. Yim, S. L. Bek, et al. Acute Respiratory Distress Syndrome in Critically Ill Patients With Severe Acute Respiratory Syndrome JAMA, July 16, 2003; 290(3): 374 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Vincent, S. Akca, A. de Mendonca, P. Haji-Michael, C. Sprung, R. Moreno, M. Antonelli, and P. M. Suter The Epidemiology of Acute Respiratory Failure in Critically Ill Patients* Chest, May 1, 2002; 121(5): 1602 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Nuckton, J. A. Alonso, R. H. Kallet, B. M. Daniel, J.-F. Pittet, M. D. Eisner, and M. A. Matthay Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress Syndrome N. Engl. J. Med., April 25, 2002; 346(17): 1281 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. El-Solh, P. Sikka, E. Bozkanat, W. Jaafar, and J. Davies Morbid Obesity in the Medical ICU Chest, December 1, 2001; 120(6): 1989 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Zwischenberger, S. K. Alpard, W. Tao, D. J. Deyo, and A. Bidani Percutaneous extracorporeal arteriovenous carbon dioxide removal improves survival in respiratory distress syndrome: A prospective randomized outcomes study in adult sheep J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 542 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Goodman, R. Fumagalli, P. Tagliabue, M. Tagliabue, M. Ferrario, L. Gattinoni, and A. Pesenti Adult Respiratory Distress Syndrome Due to Pulmonary and Extrapulmonary Causes: CT, Clinical, and Functional Correlations Radiology, November 1, 1999; 213(2): 545 - 552. [Abstract] [Full Text] |
||||
![]() |
L. D. Hudson and K. P. Steinberg Epidemiology of Acute Lung Injury and ARDS Chest, July 1, 1999; 116(2007): 74S - 82S. [Full Text] |
||||
![]() |
A. P. Wheeler and G. R. Bernard Treating Patients with Severe Sepsis N. Engl. J. Med., January 21, 1999; 340(3): 207 - 214. [Full Text] [PDF] |
||||
![]() |
G. UMBERTO MEDURI, E. A. TOLLEY, A. CHINN, F. STENTZ, and A. POSTLETHWAITE Procollagen Types I and III Aminoterminal Propeptide Levels during Acute Respiratory Distress Syndrome and in Response to Methylprednisolone Treatment Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1432 - 1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. MONCHI, F. BELLENFANT, A. CARIOU, L.-M. JOLY, D. THEBERT, I. LAURENT, J.-F. DHAINAUT, and F. BRUNET Early Predictive Factors of Survival in the Acute Respiratory Distress Syndrome . A Multivariate Analysis Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1076 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. U. Meduri, A. S. Headley, E. Golden, S. J. Carson, R. A. Umberger, T. Kelso, and E. A. Tolley Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome: A Randomized Controlled Trial JAMA, July 8, 1998; 280(2): 159 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. ARTIGAS, G. R. BERNARD, J. CARLET, D. DREYFUSS, L. GATTINONI, L. HUDSON, M. LAMY, J. J. MARINI, M. A. MATTHAY, M. R. PINSKY, et al. The American-European Consensus Conference on ARDS, Part 2 . Ventilatory, Pharmacologic, Supportive Therapy, Study Design Strategies, and Issues Related to Recovery and Remodeling Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1332 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Uchiba, K. Okajima, K. Murakami, M. Johno, M. Mohri, H. Okabe, and K. Takatsuki rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation Am J Physiol Lung Cell Mol Physiol, October 1, 1997; 273(4): L889 - L894. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Kollef and D. P. Schuster The Acute Respiratory Distress Syndrome N. Engl. J. Med., January 5, 1995; 332(1): 27 - 37. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |